2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-3-oxo-1-phenylbutyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid

2-amino-5-[[1-(carboxymethylamino)-3-(2-hydroxy-3-oxo-1-phenylbutyl)sulanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid

VVPZZZYWRZVCIP-UHFFFAOYSA-N CHEBI:193898 0 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

0 Reactome pathways

Metabolite details

Identifier: VVPZZZYWRZVCIP-UHFFFAOYSA-N
InChI Key: VVPZZZYWRZVCIP-UHFFFAOYSA-N
IUPAC name: 2-amino-5-[[1-(carboxymethylamino)-3-(2-hydroxy-3-oxo-1-phenylbutyl)sulanyl-1-oxopropan-2-yl]amino]-5-oxopentanoic acid
Preferred name: 2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-[(2-hydroxy-3-oxo-1-phenylbutyl)sulfanyl]ethyl}-C-hydroxycarbonimidoyl)butanoic acid
INN name: —
Synonym: —
ChEBI: CHEBI:193898

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)

Observed in differential profiles

G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47